RAND's divisions conduct research on a uniquely broad front for clients around the globe.
Most relevant regions
Project
Aug 19, 2026
RAND Europe evaluated the commissioning and delivery of community-based tobacco dependency treatment services for people with severe mental illness.
Research
Aug 17, 2026
The research highlights the importance of a tailored service for people with severe mental illness, but that additional metrics could be more broadly captured on service user outcomes and service costs.
This paper tests two culturally grounded virtual interventions for substance use among urban American Indian and Alaska Native emerging adults.
Aug 10, 2026
RAND Europe evaluated the implementation and delivery of Individual Placement and Support, an evidence-based intervention to support people into employment.
Commentary
Epidemic and pandemic threats are a matter of national, regional, and international security. The evolving risks demand strengthened collaboration across the health and defence communities to bring their unique expertise and resources to bear, to prepare faster and more effectively.
This paper explores how the Individual Placement and Support model has been adapted for delivery in drug and alcohol treatment services in England.
This paper explores clients’ views and experiences of Individual Placement and Support for substance use to understand how the program is working across England, and whether any improvements can be made.
Jul 16, 2026
In this study, we compare the availability of medication for opioid use disorder options, psychosocial services, and housing supports across OTPs operating in states with different levels of OTP policy restrictions.
We examined associations between coverage-promoting policies and changes in initiation and discontinuation of buprenorphine treatment during Medicaid unwinding.
Findings suggest that funding stability and lack of adequate post-discharge treatment services are ongoing barriers to addiction consultation services sustainability.
Jul 15, 2026
We sought to understand the association of stimulant use with social needs and opioid use disorder and mental illness severity and treatment.
Jun 29, 2026
This study assesses the duration of buprenorphine episodes paid by fee-for-service and managed care organization plans with and without prior authorization (PA) in Medicaid.